Research

Get the latest details on current events, medical progress, and therapies used by mesothelioma patients around the globe. Learn More.

Alternatives | Chemotherapy | New Drugs | New Studies | Research | Treatments | Updates

Scrubbed Trial May Not Be the End for Mesothelioma Drug
ByAlex Strauss September 28, 2015March 16, 2017

The makers of the once-promising experimental mesothelioma drug defactinib have announced that they will stop a clinical trial of the…

Read More Scrubbed Trial May Not Be the End for Mesothelioma Drug
Alternatives | Asbestos | New Studies | Prevention | Research | Updates

Mesothelioma Awareness Day Shines Spotlight on the Danger of Asbestos
ByAlex Strauss September 25, 2015March 16, 2017

Organizers of the annual Mesothelioma Awareness Day are encouraging patients, families, advocates and those who have lost loved ones to…

Read More Mesothelioma Awareness Day Shines Spotlight on the Danger of Asbestos
Australia | Chemotherapy | Immune Systems | Immunotherapy | International | Mesothelioma | Multi-Modality Therapy | Research | Treatments | Updates

Long Term Mesothelioma Survival with Immune System Activation
ByAlex Strauss September 21, 2015March 16, 2017

A small group of Australian mesothelioma patients have reportedly lived more than twice as long as expected with a combination…

Read More Long Term Mesothelioma Survival with Immune System Activation
Asbestos | Europe | Genetics | International | Research | Statistics | Updates

Could Other Gene Mutations Be Behind Mesothelioma?
ByAlex Strauss September 18, 2015March 16, 2017

A mutation of the BAP1 gene may not be the only reason mesothelioma can sometimes run in families. A more…

Read More Could Other Gene Mutations Be Behind Mesothelioma?
Chemotherapy | Glocal | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments | Updates

Clinical Trial May be Best Second-Line Approach for Mesothelioma
ByAlex Strauss September 15, 2015March 16, 2017

The best second-line treatment for mesothelioma patients who fail to respond to standard chemotherapy is probably to enroll in a…

Read More Clinical Trial May be Best Second-Line Approach for Mesothelioma
Immune Systems | Immunotherapy | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments | Updates | Virus

Emerging Therapies Target Mesothelioma in New Ways
ByAlex Strauss August 27, 2015March 16, 2017

Targeted therapies may be the future of mesothelioma treatment. That word comes from a team of some of the world’s…

Read More Emerging Therapies Target Mesothelioma in New Ways
Chemotherapy | Europe | International | Multi-Modality Therapy | New Studies | Prognosis | Research | Treatments | Updates

Improving Mesothelioma Response to Chemotherapy
ByAlex Strauss August 26, 2015March 16, 2017

Most mesothelioma patients will undergo chemotherapy at some point, whether in preparation for surgery or as a treatment by itself.…

Read More Improving Mesothelioma Response to Chemotherapy
Biological Therapy | Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments | Updates

Making Mesothelioma Cells More Susceptible to Chemotherapy
ByAlex Strauss August 22, 2015March 25, 2019

A potential new mesothelioma drug may have moved a step closer to gaining mainstream acceptance for use in sick patients.…

Read More Making Mesothelioma Cells More Susceptible to Chemotherapy
Asia | Genetics | International | Mesothelioma | New Drugs | Research | Treatments | Updates | Virus

Could a Virus-Delivered Gene Slow Mesothelioma Growth?
ByAlex Strauss August 11, 2015March 21, 2019

Researchers in Japan are enrolling mesothelioma patients into a trial to test whether blocking a growth signaling pathway inside mesothelioma cells…

Read More Could a Virus-Delivered Gene Slow Mesothelioma Growth?
Europe | Immune Systems | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments | Updates

Kidney Cancer Drug Slows Mesothelioma Growth in Mice
ByAlex Strauss August 8, 2015March 24, 2019

A drug that has been shown to slow the growth of renal cell carcinoma may have moved a step closer…

Read More Kidney Cancer Drug Slows Mesothelioma Growth in Mice

1 (888) 378-1331

Research

Scrubbed Trial May Not Be the End for Mesothelioma Drug

Mesothelioma Awareness Day Shines Spotlight on the Danger of Asbestos

Long Term Mesothelioma Survival with Immune System Activation

Could Other Gene Mutations Be Behind Mesothelioma?

Clinical Trial May be Best Second-Line Approach for Mesothelioma

Emerging Therapies Target Mesothelioma in New Ways

Improving Mesothelioma Response to Chemotherapy

Making Mesothelioma Cells More Susceptible to Chemotherapy

Could a Virus-Delivered Gene Slow Mesothelioma Growth?

Kidney Cancer Drug Slows Mesothelioma Growth in Mice

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES